MedTrace Logo

Telemonitoring in Arterial Hypertension

NCT07049289 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-07-03

No results posted yet for this study

Summary

Prospective, randomized trial to assess the effects of a telemedical approach of antihypertensive treatment in comparison with standard care.

Total patient number: 60 patients.

* Intervention group: biweekly telephone calls
* Control group: standard of care

Conditions

Interventions

OTHER

Telemonitoring

Patients randomized to intervention group will receive biweeky telephone calls and adaption of antiyhpertensive medication if needed

Sponsors & Collaborators

  • Heart Center Leipzig - University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-13
Primary Completion
2025-03-09
Completion
2025-09-09

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07049289 on ClinicalTrials.gov